홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Potassium Carbonate → HCID 178429465, 화합물

HRID 577118
인쇄

반응식

HRID 577118 반응식
Br[CH2:2][C:3]1[N:7]([CH3:8])[CH:6]=[N:5][C:4]=1[Cl:9].C(=O)([O-])[O-].[K+].[K+].[CH3:16][C:17]1[N:22]=[C:21]([SH:23])[N:20]=[C:19]([OH:24])[CH:18]=1>CN(C=O)C>[Cl:9][C:4]1[N:5]=[CH:6][N:7]([CH3:8])[C:3]=1[CH2:2][S:23][C:21]1[N:20]=[C:19]([OH:24])[CH:18]=[C:17]([CH3:16])[N:22]=1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

5

반응물 3

HCID 11430Potassium CarbonateHCID 595893705-(bromomethyl)-4-chloro-1-methyl-1H-imidazoleHCID 178429541HCID 178429541, 화합물

생성물 1

HCID 178429465HCID 178429465, 화합물

시약·촉매·용매 1

HCID 6228Dimethylformamide용매

실험 절차

5-(bromomethyl)-4-chloro-1-methyl-1H-imidazole was dissolved in DMF (20 mL). Potassium carbonate (3 g) and 6-methyl-2-sulfanylpyrimidin-4-ol (1.4 g, 10 mmol) were added. The new mixture was stirred at room temperature for 2 hours. DMF was removed under vacuum. The crude compound was purified by column chromatography to provide 2-{[(4-chloro-1-methyl-1H-imidazol-5-yl)methyl]sulfanyl}-6-methylpyrimidin-4-ol as the major product (350 mg, 13% overall yield); 1H NMR (400 MHz, DMSO-d6): δ 2.19 (s, 3H), 3.72 (s, 3H), 4.59 (s, 2H), 6.00 (bs, 1H), 7.59 (s, 1H); M+ 271.

후처리

  1. customDMF was removed under vacuum
  2. customThe crude compound was purified by column chromatography

출처 및 근거

ORD 기록
ord-340b72e55299477188c307d9a0d295ed
출처 데이터셋
uspto-grants-2015_05
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US09040538B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트